Don't Use Hetlioz for Most Insomnia Patients

September 2015

Patients are asking about Hetlioz (HET-lee-owz, tasimelteon) for "non-24"...due to all the TV, internet, and magazine ads.

It's a melatonin-receptor agonist similar to Rozerem (ramelteon). But Hetlioz is approved for non-24-hour sleep-wake disorder.

Non-24 is a circadian disorder where patients can't synchronize their internal clock to the 24-hour light-dark cycle. It occurs in over half of blind people...but is very rare in sighted people.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Cardiology Save Entresto for Persistent Heart Failure Symptoms
Influenza Don't Automatically Give the Live Intranasal Vaccine to Kids
NSAIDs Limit NSAIDs in Patients With Cardiovascular Disease
Cardiology Don't Routinely Use Praluent for High Cholesterol
Pharmacogenetics Be Aware of Situations Where Pharmacogenetic Testing Makes Sense
Infectious Diseases Dispel the Myth That Discolored Nasal Mucus Always Means a Bacterial Infection
Gastroenterology Explain That Any Risk of Heart Attack With PPIs Is Very Small
Otics Consider Alternatives for Unapproved Otics
Stroke Don't Jump to Clopidogrel if Patients Have a GI Bleed on Aspirin
Antipsychotics Ensure Patients Get At Least 4 Months of Invega Sustenna BEFORE Invega Trinza
Lice Advise Reapplying Nix in 7 to 10 Days Even if Labels Say Otherwise
Sleep Disorders Don't Use Hetlioz for Most Insomnia Patients

Don't Use Hetlioz for Most Insomnia Patients

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents